K-V Pharmaceutical (KVPHQ) Says Bankruptcy Court Approves Hologic (HOLX) Settlement
K-V Pharmaceutical Company (OTC: KVPHQ) (NYSE: KV-A) today announced that the U. S. Bankruptcy Court for the Southern District of New York, the Honorable Judge Allan L. Gropper presiding, approved the Company's settlement agreement with Hologic, Inc. (Nasdaq: HOLX), and authorized the Company to enter into an $85 million debtor-in-possession financing to, among other things, fund the settlement.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Teva Pharma (TEVA) to Appeal PTAB's Decisions on Two COPAXONE Patents
- Ballard Power's (BLDP) Protonex Becomes EAR99 Compliant
- Senate Special Committee on Aging Seeks Briefing From Mylan (MYL) Over Epipen Pricing
Create E-mail Alert Related CategoriesCorporate News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!